期刊文献+

临床药师全程参与甲状腺功能亢进症伴肝损害患者药学实践的效果分析

Effect of Clinical Pharmacists'Full Participation in Pharmaceutical Practice in Patients with Hyperthyroidism and Liver Damage
下载PDF
导出
摘要 目的:分析临床药师全程参与甲状腺功能亢进症(简称甲亢)伴肝损害患者药学实践的效果。方法:选取2022年1月—2023年12月徐州市沛县人民医院收治的甲亢伴肝损害患者76例为研究对象,采用随机数字表法分为对照组和观察组,各38例。对照组实施常规药学实践,观察组在对照组基础上实施临床药师全程参与的药学实践模式。对比两组服药依从性、不良反应发生率。结果:观察组服药总依从率高于对照组(P=0.033);观察组不良反应总发生率低于对照组(P=0.017)。结论:对甲亢伴肝损害患者采用临床药师全程参与药学实践模式可以提高其服药依从性,降低不良反应发生率。 Objective:To analyze the effect of clinical pharmacists'full participation in the pharmacy practice of patients with hyperthyroidism and liver damage.Methods:A total of seventy-six patients with hyperthyroidism and liver damage treated in Xuzhou Pei County People's Hospital from January 2022 to December 2023 were selected as the study objects,and were divided into control group and observation group by random number table method,with thirty-eight cases in each group.The control group implemented the routine pharmacy practice,and the observation group implemented the pharmacy practice mode with the full participation of clinical pharmacists on the basis of the control group.The medication compliance and incidence of adverse reactions were compared between the two groups.Results:The total compliance rate of observation group was higher than that of control group(P=0.033);the total incidence of adverse reactions in observation group was lower than that in control group(P=0.017).Conclusion:For patients with hyperthyroidism and liver damage,the full participation of clinical pharmacists in pharmaceutical practice can improve their medication compliance and reduce the incidence of adverse reactions.
作者 李小凤 Li Xiaofeng(Department of Pharmacy,Xuzhou Pei County People's Hospital,Xuzhou 221600,Jiangsu Province,China)
出处 《中外医药研究》 2024年第23期9-11,共3页 JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
关键词 甲状腺功能亢进症 肝损害 临床药师 依从性 不良反应 Hyperthyroidism Liver damage Clinical pharmacist Compliance Adverse reaction
  • 相关文献

参考文献10

二级参考文献84

  • 1王吉佳,孟玲丽,韩金霞.比较索他洛尔和普罗帕酮治疗心律不齐的疗效[J].中国农村卫生,2020(8):89-89. 被引量:2
  • 2杜昕,刘晓惠,马长生.心房颤动的药物治疗[J].中华心律失常学杂志,2005,9(2):129-132. 被引量:33
  • 3蔡晓频,杨文英,杨兆军,陈燕燕,卜石.抗甲状腺药物致粒细胞缺乏症6例临床分析[J].中国实用内科杂志,2005,25(8):731-732. 被引量:12
  • 4刘建平,徐琳琳,彭涛,王虹,王兰.索他洛尔联合普罗帕酮治疗阵发性房颤的效果观察[J].实用医药杂志,2006,23(9):1037-1038. 被引量:2
  • 5白耀.甲状腺病学-基础与临床[M].北京:科学技术文献出版社,2004.388.
  • 6Davies TF, Larsen PR. Thyrotixicosis// Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia: Saunders, 2002: 374-424.
  • 7Chiovato L, Babesino G, Pinchera A. Graves disease//DeGroot LJ, Jameson JL. Endocrinology. 4th ed. Philadelphia: Saunders, 2001 : 1422-1449.
  • 8Greenspan FS. The thyroid gland//Greenspan FS, Gardner DG. Basic and clinical endocrinology. New York: Lange /McGraw- Hill, 2001: 201-272.
  • 9Fisher DA. Disorders of the thyroid in the newborn and infant// Sperling MA. Pediatric endocrinology. 2nd ed. Philadelphia: Sannders, 2002 : 161-186.
  • 10Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med, 2000, 160:1573-1575.

共引文献852

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部